{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:25:27Z","timestamp":1773408327103,"version":"3.50.1"},"reference-count":77,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In addition to the spectrum of conditions known collectively as the Metabolic Syndrome, obesity is now recognized to be associated with increased risk of several cancers including colon, endometrial, and breast cancer. Obesity and carcinogenesis share 2 characteristics in common. On the one hand, they involve inflammatory pathways, and on the other hand, they involve dysregulated metabolism. In this review we focus on postmenopausal breast cancer and discuss the metabolic and cellular mechanisms whereby obesity and breast cancer are related. Because a majority of postmenopausal breast tumors are estrogen responsive, we include a discussion of the action of obesity-related factors on estrogen formation within the breast.<\/jats:p>","DOI":"10.1210\/me.2013-1011","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T03:18:15Z","timestamp":1363922295000},"page":"715-725","source":"Crossref","is-referenced-by-count":67,"title":["Minireview: Obesity and Breast Cancer: A Tale of Inflammation and Dysregulated Metabolism"],"prefix":"10.1210","volume":"27","author":[{"given":"Evan R.","family":"Simpson","sequence":"first","affiliation":[{"name":"Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Victoria 3168, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristy A.","family":"Brown","sequence":"additional","affiliation":[{"name":"Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Victoria 3168, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071614064681500_B1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1008995217664","article-title":"A prospective study of obesity and cancer risk (Sweden)","volume":"12","author":"Wolk","year":"2001","journal-title":"Cancer Causes Control"},{"key":"2020071614064681500_B2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/157339912799424519","article-title":"Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy","volume":"8","author":"Vona-Davis","year":"2012","journal-title":"Curr. Diabetes Rev"},{"key":"2020071614064681500_B3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/oxfordjournals.aje.a010275","article-title":"Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study","volume":"151","author":"Hall","year":"2000","journal-title":"Am J Epidemiol"},{"key":"2020071614064681500_B4","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1200\/JCO.2010.33.6446","article-title":"Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women","volume":"29","author":"Lee","year":"2011","journal-title":"J Clin Oncol"},{"key":"2020071614064681500_B5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"2020071614064681500_B6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Contribution to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2020071614064681500_B7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.2004-0020","article-title":"Estrogen\u2014the good, the bad and the unexpected","volume":"26","author":"Simpson","year":"2005","journal-title":"Endocr Rev"},{"key":"2020071614064681500_B8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0002-9378(78)90287-9","article-title":"Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer","volume":"130","author":"MacDonald","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"2020071614064681500_B9","first-page":"428","article-title":"Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age","volume":"78","author":"Bulun","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614064681500_B10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Ann Rev Physiol"},{"key":"2020071614064681500_B11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ijo.2008.229","article-title":"Emerging role of adipose tissue hypoxia in obesity and insulin resistance","volume":"33","author":"Ye","year":"2009","journal-title":"Int J Obes"},{"key":"2020071614064681500_B12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol"},{"key":"2020071614064681500_B13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","article-title":"Inflammation and lipid signaling in the etiology of insulin resistance","volume":"15","author":"Glass","year":"2012","journal-title":"Cell Metab"},{"key":"2020071614064681500_B14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10549-012-2053-1","article-title":"NF\u03ba\u03b2 signaling is important for growth of antiestrogen resistant breast cancer cells","volume":"135","author":"Yde","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"2020071614064681500_B15","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1054\/bjoc.2000.1709","article-title":"Breast cancer and NSAID use: a meta-analysis","volume":"84","author":"Khuder","year":"2001","journal-title":"Br J Cancer"},{"key":"2020071614064681500_B16","first-page":"632","article-title":"Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer","volume":"62","author":"Ristim\u00e4ki","year":"2002","journal-title":"Cancer Res"},{"key":"2020071614064681500_B17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/labinvest.2012.90","article-title":"Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model","volume":"92","author":"Xin","year":"2012","journal-title":"Lab Invest"},{"key":"2020071614064681500_B18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.physiol.64.081601.142703","article-title":"Aromatase\u2014A brief review","volume":"64","author":"Simpson","year":"2002","journal-title":"Ann Rev Physiol"},{"key":"2020071614064681500_B19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1158\/0008-5472.657.65.2","article-title":"Interactions between prostaglandin E2 liver receptor homologue-1, and aromatase in breast cancer","volume":"65","author":"Zhou","year":"2005","journal-title":"Cancer Res"},{"key":"2020071614064681500_B20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1940-6207.CAPR-11-0110","article-title":"Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer","volume":"4","author":"Morris","year":"2011","journal-title":"Cancer Prev Res"},{"key":"2020071614064681500_B21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1158\/2159-8290.CD-11-0241","article-title":"Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women","volume":"2","author":"Subbaramaiah","year":"2012","journal-title":"Cancer Discov"},{"key":"2020071614064681500_B22","first-page":"1622","article-title":"A link between breast cancer and local estrogen synthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription","volume":"77","author":"Bulun","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614064681500_B23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bmj.296.6624.741","article-title":"Aromatase activity in adipose tissue from breast quadrants:a link with tumour site","volume":"296","author":"O'Neill","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2020071614064681500_B24","first-page":"3843","article-title":"Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients","volume":"81","author":"Agarwal","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614064681500_B25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"2020071614064681500_B26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/iub.93","article-title":"Hypoxia inducible factor 1 and cancer pathogenesis","volume":"60","author":"Semenza","year":"2008","journal-title":"IUBMB Life"},{"key":"2020071614064681500_B27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR Complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol Cell"},{"key":"2020071614064681500_B28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","article-title":"SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth","volume":"8","author":"Porstmann","year":"2008","journal-title":"Cell Metab"},{"key":"2020071614064681500_B29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrc2715","article-title":"p53 and metabolism","volume":"9","author":"Vousden","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2020071614064681500_B30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat Cell Biol"},{"key":"2020071614064681500_B31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"2020071614064681500_B32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2012.01.001","article-title":"Connecting threads: epigenetics and metabolism","volume":"148","author":"Katada","year":"2012","journal-title":"Cell"},{"key":"2020071614064681500_B33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"The Encode Project Consortium","year":"2012","journal-title":"Nature"},{"key":"2020071614064681500_B34","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2741\/3810","article-title":"Associations between adipokines and obesity-related cancer","volume":"16","author":"Paz-Filho","year":"2011","journal-title":"Frontiers Biosci"},{"key":"2020071614064681500_B35","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s10620-008-0585-3","article-title":"Adipose tissue:the new endocrine organ? A review article","volume":"54","author":"Wozniak","year":"2009","journal-title":"Digest Dis Sci"},{"key":"2020071614064681500_B36","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1530\/ERC-11-0374","article-title":"Obesity, type 2 diabetes and cancer: the insulin and IGF connection","volume":"19","author":"Cohen","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"2020071614064681500_B37","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1158\/0008-5472.CAN-10-4158","article-title":"Transcriptional control of cellular metabolism by mTOR signaling","volume":"71","author":"Yecies","year":"2011","journal-title":"Cancer Res"},{"key":"2020071614064681500_B38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2012.05.010","article-title":"p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake","volume":"16","author":"Dagon","year":"2012","journal-title":"Cell Metab"},{"key":"2020071614064681500_B39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/fon.09.174","article-title":"AMPK as a metabolic tumor suppressor control of metabolism and cell growth","volume":"6","author":"Luo","year":"2010","journal-title":"Future Oncol"},{"key":"2020071614064681500_B40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1081\/CNV-200027144","article-title":"The tuberous sclerosis complex genes in tumor development","volume":"22","author":"Mak","year":"2004","journal-title":"Cancer Invest"},{"key":"2020071614064681500_B41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","article-title":"AMP-activated protein kinase induces a p53-dependent metabolic checkpoint","volume":"18","author":"Jones","year":"2005","journal-title":"Mol Cell"},{"key":"2020071614064681500_B42","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1038\/onc.2010.393","article-title":"Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis","volume":"29","author":"Lacher","year":"2010","journal-title":"Oncogene"},{"key":"2020071614064681500_B43","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/onc.2009.129","article-title":"LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells","volume":"28","author":"Taliaferro-Smith","year":"2009","journal-title":"Oncogene"},{"key":"2020071614064681500_B44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1472-6750-11-90","article-title":"Design and development of a peptide-based adiponectin receptor agonist for cancer treatment","volume":"11","author":"Otvos","year":"2011","journal-title":"BMC Biotechnol"},{"key":"2020071614064681500_B45","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1158\/0008-5472.CAN-09-0108","article-title":"Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription factor 2 provides a link between obesity and breast cancer in postmenopausal women","volume":"69","author":"Brown","year":"2009","journal-title":"Cancer Res"},{"key":"2020071614064681500_B46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/0008-5472.CAN-09-2257","article-title":"Obesity and breast cancer: progress to understanding the relationship","volume":"70","author":"Brown","year":"2010","journal-title":"Cancer Res"},{"key":"2020071614064681500_B47","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature03967","article-title":"The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism","volume":"437","author":"Koo","year":"2005","journal-title":"Nature"},{"key":"2020071614064681500_B48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10549-010-0854-7","article-title":"COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients","volume":"125","author":"Van Nes","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"2020071614064681500_B49","first-page":"3468","article-title":"Use of aspirin, other non-steroidal anti-inflammatory drugs, and acetaminophen and post-menopausal breast cancer incidence","volume":"30","author":"Zhang","year":"2012"},{"key":"2020071614064681500_B50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2407-6-27","article-title":"Reduction in the risk of human breast cancer by selective cyclo-oxygenase-2 (COX-2) inhibitors","volume":"6","author":"Harris","year":"2006","journal-title":"BMC Cancer"},{"issue":"2","key":"2020071614064681500_B51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.seminoncol.2004.03.042","article-title":"The role of COX-2 inhibition in breast cancer treatment and prevention","volume":"31","author":"Arun","year":"2004","journal-title":"Semin Oncol"},{"key":"2020071614064681500_B52","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/labinvest.2012.90","article-title":"Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model","volume":"92","author":"Xin","year":"2012","journal-title":"Lab Invest"},{"key":"2020071614064681500_B53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.prostaglandins.2006.07.003","article-title":"Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions PII, I.3 and pI.7 and estradiol production in human breast tumor cells","volume":"81","author":"Prosperi","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2020071614064681500_B54","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1074\/jbc.R600038200","article-title":"Prostaglandin E receptors","volume":"282","author":"Sugimoto","year":"2007","journal-title":"J Biol Chem"},{"key":"2020071614064681500_B55","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10549-011-1675-z","article-title":"Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2","volume":"132","author":"Ma","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"2020071614064681500_B56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.mce.2012.06.016","article-title":"Endocrine related cancers and the role of AMPK","volume":"366","author":"Brown","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"2020071614064681500_B57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1749-6632.2011.06285.x","article-title":"Diabetes, cancer and Metformin: connections of metabolism and cell proliferation","volume":"1243","author":"Gallagher","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"2020071614064681500_B58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethyl biguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El Mir","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071614064681500_B59","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","article-title":"AMPK in health and disease","volume":"89","author":"Steinberg","year":"2009","journal-title":"Physiol Rev"},{"key":"2020071614064681500_B60","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.chembiol.2012.08.019","article-title":"AMP-activated protein kinase: a target for drugs both ancient and modern","volume":"19","author":"Hardie","year":"2012","journal-title":"Chem Biol"},{"key":"2020071614064681500_B61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10549-011-1612-1","article-title":"Evidence for biological effects of Metformin in operable breast cancer: a pre-operative window-of-opportunity, randomized trial","volume":"128","author":"Hadad","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"2020071614064681500_B62","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4161\/cc.8.10.8406","article-title":"Genome-wide inhibitory impact of the AMPK activator Metformin on M-phase cell cycle genes in human breast cancer cells","volume":"8","author":"Oliveras-Ferraros","year":"2009","journal-title":"Cell Cycle"},{"key":"2020071614064681500_B63","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","article-title":"Systemic treatment with antidiabetic drug Metformin selectively impairs p53-deficient tumor cell growth","volume":"67","author":"Buzzai","year":"2007","journal-title":"Cancer Res"},{"key":"2020071614064681500_B64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-2187-3-18","article-title":"Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1","volume":"3","author":"Zhuang","year":"2008","journal-title":"J Mol Signal"},{"key":"2020071614064681500_B65","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","article-title":"The antidiabetic drug Metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level","volume":"27","author":"Ben Sahra","year":"2008","journal-title":"Oncogene"},{"key":"2020071614064681500_B66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-008-9916-5","article-title":"Therapeutic Metformin\/AMPK activation promotes the angiogenic phenotype in the ER\u03b1 negative MDA-MB-435 breast cancer model","volume":"113","author":"Phoenix","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"2020071614064681500_B67","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res"},{"key":"2020071614064681500_B68","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.ejca.2010.06.012","article-title":"Metformin: taking away the candy for cancer?","volume":"46","author":"Jalving","year":"2010","journal-title":"Eur J Cancer"},{"key":"2020071614064681500_B69","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-010-0834-y","article-title":"Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase","volume":"123","author":"Brown","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"2020071614064681500_B70","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.steroids.2011.02.041","article-title":"Promoter-specific effects of Metformin on aromatase transcript expression","volume":"76","author":"Samarajeewa","year":"2011","journal-title":"Steroids"},{"key":"2020071614064681500_B71","doi-asserted-by":"crossref","first-page":"39247","DOI":"10.1074\/jbc.M111.264598","article-title":"Targeting energy metabolic and oncogenic signalling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator","volume":"286","author":"Lee","year":"2011","journal-title":"J Biol Chem"},{"key":"2020071614064681500_B72","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cmet.2007.08.014","article-title":"SIRT1 improves insulin sensitivity under insulin resistant conditions by repressint PTP1B","volume":"6","author":"Sun","year":"2007","journal-title":"Cell Metab"},{"key":"2020071614064681500_B73","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/gerona\/glr235","article-title":"Pilot study of resveratrol in older adults with impaired glucose tolerance","volume":"67","author":"Crandall","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2020071614064681500_B74","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cmet.2012.09.015","article-title":"Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance","volume":"16","author":"Yoshino","year":"2012","journal-title":"Cell Metab"},{"key":"2020071614064681500_B75","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","article-title":"Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases","volume":"148","author":"Park","year":"2012","journal-title":"Cell"},{"key":"2020071614064681500_B76","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/jf9035782","article-title":"Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation","volume":"58","author":"Lin","year":"2010","journal-title":"J Agric Food Chem"},{"key":"2020071614064681500_B77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/toxsci\/kfj190","article-title":"The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells","volume":"92","author":"Wang","year":"2006","journal-title":"Toxicol Sci"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/27\/5\/715\/8936887\/mend0715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/27\/5\/715\/8936887\/mend0715.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T20:18:38Z","timestamp":1715113118000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/27\/5\/715\/2615048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,1]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2013-1011","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,1]]}}}